Immune Tolerance Network (UM1 Clinical Trial Required)
The purpose of this notice of funding opportunity (NOFO) is to support applications to continue the Immune Tolerance Network (ITN). The primary objective of the Network is to develop tolerogenic therapies for immune-mediated disorders. The three main clinical areas of work are: 1) Allergic diseases …
Closes 29 Jan 2027 (86 days)
up to USD 27,000,000. National Institutes of Health
Who can apply
- Where
- United States, nationwide
- Industries
- any, or not stated
- Business size
- not stated
- Amount
- up to USD 27,000,000
- Dates
- opens 20 Oct 2026; closes 29 Jan 2027
The funder's text has not been read for criteria yet; open the source for the full rules.
Eligibility, in the funder's words
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
About the program
The purpose of this notice of funding opportunity (NOFO) is to support applications to continue the Immune Tolerance Network (ITN). The primary objective of the Network is to develop tolerogenic therapies for immune-mediated disorders. The three main clinical areas of work are: 1) Allergic diseases and asthma; 2) Autoimmune diseases; and 3) Immune-mediated consequences of transplantation. The core functions of the ITN include designing, conducting, and sharing the results of clinical trials and performing integrated mechanistic studies.
Common questions
Am I eligible?
Only National Institutes of Health can say. The rules above are what the notice states; sign in and your business profile is compared with them line by line for a likely, maybe or unlikely verdict.
When does it close?
29 Jan 2027. Save it in your account for reminders 14, 7 and 2 days before.
Where do I apply?
On the funder's page: https://www.grants.gov/search-results-detail/362946
Is this one for you?
Sign in and your state, industry, size and turnover are compared with these rules line by line. Save it for closing reminders.